Indian Spinal Injuries Center treated an unusual case of a banker diagnosed with tuberculosis which subsequently spread to her bones making her limp with pain that was deteriorating. Her condition not just failed to improve; she additionally developed a progressive pain in her left hip causing her limp.
At the point when the pain worsened consistently, the patient was presented to Indian Spinal Injuries Center, where she was diagnosed as a case of drug-resistant tuberculosis that had now spread to the bones. In spite of regular chemotherapy, she developed evidence of the disease spreading to different parts of her body.
Dr. Ritabh Kumar, senior consultant, orthopedics and trauma surgery, Indian Spinal Injuries Centre said, “The woman was on first generation anti-tubercular drugs for more than a year and a half for pulmonary tuberculosis. Even with drug resistance, the disease had begun eating into her bones. The tests conducted demonstrated the erosion of the femur bone and moreover, showed frank pus surrounding the upper end of the thigh bone. Not only did she require treatment for drug-resistant TB, she also needs immediate surgical intervention to decompress the infection in the hip joint that was causing her the pain and limp”.
Dr. Kumar additionally said, “The disease had spread to damage the tissue in the proximal left hip region and the damaged tissue should have been removed. In this way, surgical debridement of the hip bone was conducted to reduce the disease burden and obtain tissue material for the culture of the offending organism.
The tissue demonstrated the tubercular bacteria under the microscope and the cultures grew the bacteria resistant to the two most vital drugs in our fight against this disease.” The patient showed results of recovery at the postoperative stage and came back to her job.
She, however, proceeds with her consultation and regular check-ups with her physicians. Dr. Kumar says, “Tuberculosis is endemic in our subcontinent and nobody is immune to it. An unfortunate trend is that the incidence of drug resistance is increasing. This poses challenges for physicians to treat however furthermore, escalates the cost of treatment and incidences of side-effects for the patients”.
Physicians at Indian Spinal Injuries Center said drug-resistant tuberculosis today has turned out to be more across the board than we imagine.
As per WHO, such strain has been reported for in 117 nations around the world. While TB can indeed affect various organs such as lungs, kidney, lymph nodes, bones, joints, just around 5-10% of the total TB patients in India are suffering bone TB, recommends clinical evidence.
Then again, rarely have persons with drug-resistant tuberculosis gone on to develop Bone TB. Drug-resistant TB has as often as possible been encountered in India, and the numbers are increasing throughout a previous couple of years, suggest different studies.
In spite of the fact that enrolment for treatment programs for individuals with MDR-TB had improved significantly between 2009 and 2011, the quantity of individuals getting treatment is still abysmally low in a country having one of the highest burdens of MDR-TB, reveals a report published in Lancet Infectious Diseases medical journal. India reported an estimated 64,000 cases of notified multi-drug resistant tuberculosis (MDR-TB) in 2012.
Then again, the country by and by has the highest overall general TB trouble on the planet, representing an expected one-fifth of worldwide TB cases around the world, and an expected prevalence of 3 million TB cases each year (out of which very nearly 2 million cases are new), as per information from Global Tuberculosis Report 2013 by WHO. Multidrug-safe TB (MDR-TB) is a type of TB that shows a lack of response to two most powerful anti-TB drugs.
The bacteria that cause tuberculosis (TB) can develop resistance in various cases to the antimicrobial medications used to cure the disease. Premature treatment interruption, inappropriate or incorrect utilization of antimicrobial medications or transmission of MDR TB from person to person are factors responsible for the spread of drug-resistant TB in India.